141 related articles for article (PubMed ID: 2527217)
1. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
Ishikawa T; Tanaka Y; Ishitsuka H; Ohkawa T
Jpn J Cancer Res; 1989 Jun; 80(6):583-91. PubMed ID: 2527217
[TBL] [Abstract][Full Text] [Related]
2. Optimal treatment regimens for 5'-deoxy-5-fluorouridine, with or without (E)-5-(2-bromovinyl)-2'-deoxyuridine, against various tumors in mice.
Iigo M; Miwa M; De Clercq E
Jpn J Cancer Res; 1990 Apr; 81(4):431-5. PubMed ID: 2142152
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
[TBL] [Abstract][Full Text] [Related]
4. Biological activities of 5-fluorouracil and its prodrug 5'-deoxy-5-fluorouridine in rats.
Au JL; Rustum YM; Slocum HK
Cancer Drug Deliv; 1987; 4(3):137-44. PubMed ID: 2967103
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor effect of 5'-deoxy-5-fluorouridine by oral administration with L-cysteine.
Iigo M; Nakajima Y; Araki E; Hoshi A
Jpn J Cancer Res; 1989 Feb; 80(2):182-7. PubMed ID: 2524459
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
[TBL] [Abstract][Full Text] [Related]
7. Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidine.
Ninomiya Y; Miwa M; Eda H; Sahara H; Fujimoto K; Ishida M; Umeda I; Yokose K; Ishitsuka H
Jpn J Cancer Res; 1990 Feb; 81(2):188-95. PubMed ID: 2139643
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.
Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969
[TBL] [Abstract][Full Text] [Related]
9. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H
Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effects of 5'-deoxy-5-fluorouridine (5'-DFUR) against various murine tumors in combination with recombinant interferon alpha or cytostatics].
Ninomiya Y; Miwa M; Fukuda H; Ishikawa T; Eda H; Matsuura N; Tanaka Y; Ishitsuka H
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3271-7. PubMed ID: 2961305
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of pyrimidine nucleoside phosphorylase enhances the sensitivity to 5'-deoxy-5-fluorouridine in tumour cells in vitro and in vivo.
Nagata T; Nakamori M; Iwahashi M; Yamaue H
Eur J Cancer; 2002 Mar; 38(5):712-7. PubMed ID: 11916555
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor activity of 5'-deoxy-5-fluorouridine against Lewis lung carcinoma in aged hybrid (C57BL/6 x DBA/2) F1 mice.
Fujimoto S; Wang Y; Ogawa M
J Pharmacobiodyn; 1987 Jun; 10(6):260-5. PubMed ID: 2959766
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunotoxicity assessment of N4-Trimethoxybenzoyl-5'-deoxy-5- fluorocytidine (Ro 09-1390) and 5'-deoxy-5-fluorouridine (5'-DFUR) in BDF1 mice.
Inoue T; Anderson TD; Hayes TJ; Horii I
J Toxicol Sci; 1996 Feb; 21(1):29-39. PubMed ID: 8852286
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the antitumor activities of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidine (Ro09-1390) on human digestive organ cancer xenograft lines transplanted into nude mice.
Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Araya S; Meyer C; Fukumoto M
Anticancer Drugs; 1992 Aug; 3(4):387-93. PubMed ID: 1421435
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of 5'-deoxy-5-fluorouridine in combination with recombinant human interleukin 2 on murine colon carcinoma 26.
Midoro K; Gotoh K; Houkan T; Yukishige K; Fujiwara K; Ootsu K
Jpn J Cancer Res; 1997 Mar; 88(3):306-15. PubMed ID: 9140116
[TBL] [Abstract][Full Text] [Related]
16. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with interferon-alpha in renal cell carcinoma cell lines.
Ikemoto S; Sugimura K; Yoshida N; Kuratsukuri K; Wada S; Nakatani T
Urol Int; 2004; 73(4):348-53. PubMed ID: 15604581
[TBL] [Abstract][Full Text] [Related]
17. [Effects of 5'-deoxy-5-fluorouridine on human gastrointestinal and breast cancers xenografted to nude mice].
Fujita F; Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1635-43. PubMed ID: 6236751
[TBL] [Abstract][Full Text] [Related]
18. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
Iigo M; Nishikata K; Hoshi A
Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
[TBL] [Abstract][Full Text] [Related]
19. Differential selectivity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in cultured human B lymphocytes and mouse L1210 leukemia.
Au JL; Rustum YM; Minowada J; Srivastava BI
Biochem Pharmacol; 1983 Feb; 32(3):541-6. PubMed ID: 6221728
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats.
Au JL; Walker JS; Rustum Y
J Pharmacol Exp Ther; 1983 Oct; 227(1):174-80. PubMed ID: 6225866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
